Featured Research

from universities, journals, and other organizations

Genetic Connection In Link Between Permanent Hair Dye Use And Bladder Cancer Risk

Date:
April 10, 2002
Source:
University Of Southern California
Summary:
Certain women may be more susceptible to bladder cancer associated with the use of permanent hair dyes than other women, based on their genetic makeup, according to study results released by researchers at the Keck School of Medicine of USC and colleagues.

SAN FRANCISCO, April 9 -- Certain women may be more susceptible to bladder cancer associated with the use of permanent hair dyes than other women, based on their genetic makeup, according to study results released today by researchers at the Keck School of Medicine of the University of Southern California and colleagues. Female study participants whose bodies could only slowly flush out carcinogens known as arylamines, which are an ingredient of hair dye, had a higher risk of bladder cancer than women whose bodies eliminated the carcinogens more quickly, the investigators reported. The body's efficiency in removing such toxins depends on whether someone possesses the "fast" or "slow" version of certain key genes.

Researchers presented results at the American Association of Cancer Research's 93rd Annual Meeting.

"We believe these results provide further evidence supporting a causal association between permanent hair dye use and bladder cancer risk," said Manuela Gago-Dominguez, M.D., Ph.D., researcher in preventive medicine at the Keck School and USC/Norris Comprehensive Cancer Center and lead author of the study. "They implicate the arylamines contained in hair dye solutions as the carcinogenic substances responsible for bladder cancer development in the users of these dyes." Early in 2001, USC preventive medicine researchers reported that women who use permanent dyes at least once a month for one year or longer have twice the risk of bladder cancer as non-users. Monthly or more frequent users of 15 or more years experience three times that risk even after adjusting for smoking, a known risk factor for bladder cancer.

The increase in bladder cancer risk also was observed in people who are exposed to hair dyes in their work, such as barbers and hairdressers. Increased risk was not seen for those who used temporary or semi-permanent dyes.

Gago-Dominguez explained that small amounts of arylamines are absorbed through the skin during the use of hair dye. Certain agents contained in permanent dye might cause more of the arylamines to be absorbed through the skin than in the case of temporary or semi-permanent dyes, some theorize.

Certain important, protective enzymes in the body metabolize those arylamines, trying to render them harmless. The body expels the chemicals through urine, which passes through the bladder. The efficiency of these protective enzymes depends on genes that provide the recipe for making the enzymes. The genes come in fast and slow varieties.

The research team looked at 159 female bladder cancer patients in Los Angeles and compared them to 164 similar, healthy women, analyzing their genetic makeup through blood and urine samples. They found that in women with certain slow genes (the "NAT2 slow" phenotype), exclusive permanent hair dye use was associated with a nearly tripled risk of bladder cancer.

Among women with other slow genes (the "CYP1A2 slow" phenotype), exclusive permanent hair dye use was associated with a 2.5-fold increased risk. Finally, among non-smoking women with a third type of slow genes ("NAT1 slow" genotype), exclusive permanent hair dye use was associated with a 6.8-fold increased risk.

Further study is needed to fully understand relationships between hair dyes and bladder cancer, researchers said.

Bladder cancer currently accounts for 6 percent of all new cancer cases in men and 2 percent of all new cancer cases in women. The American Cancer Society estimates that 56,500 Americans will be diagnosed with the cancer and 12,600 Americans will die from it in 2002. The research was supported by grants from the National Cancer Institute and the National Institute of Environmental Health Sciences (NIEHS).


Story Source:

The above story is based on materials provided by University Of Southern California. Note: Materials may be edited for content and length.


Cite This Page:

University Of Southern California. "Genetic Connection In Link Between Permanent Hair Dye Use And Bladder Cancer Risk." ScienceDaily. ScienceDaily, 10 April 2002. <www.sciencedaily.com/releases/2002/04/020410075652.htm>.
University Of Southern California. (2002, April 10). Genetic Connection In Link Between Permanent Hair Dye Use And Bladder Cancer Risk. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2002/04/020410075652.htm
University Of Southern California. "Genetic Connection In Link Between Permanent Hair Dye Use And Bladder Cancer Risk." ScienceDaily. www.sciencedaily.com/releases/2002/04/020410075652.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins